Antibodies, detection systems and accessories for immunohistology
Probes, kits and detection systems – visualizing DNA and RNA in tissue sections
Real-time PCR, Next Generation Sequencing (NGS) and DNA arrays – careful analysis, reliable detection
Semi-automated immunostaining systems – for maximum flexibility, highest staining quality and high throughput
Complete blocks, slide sets and individual tissue arrays – for routine and research
We are a Berlin-based company specializing in the development, manufacture and distribution of diagnostic reagents and system solutions for immunohistology, in situ hybridization and molecular pathology.
Consistent high quality is a top priority. This is why development and manufacturing of our products are governed by a quality management system certified to ISO 9001:2015 and ISO 13485:2016. A majority of the Zytomed Systems products are CE labelled and are approved as reagents for in vitro purposes (CE/IVD). See the download section for our certificates.Learn more
Ethically correct, respectful dealing with our business partners is of very high importance to Zytomed Systems GmbH and a matter of course. This includes all commercial, legal and interpersonal levels, concerns and aspects.Learn more
Thanks to our extensive network of distribution partners, you can order our products from anywhere in the world. The high degree of satisfaction of our customers speaks for itself. Our aim is to precisely tailor our products to your needs. Rely on our many years of experience, our quality, flexibility and excellent service.Learn more
Even faster NGS data analysis with the new ANDAS-T2 from AmoyDx®
For the analysis of sequencing data generated with AmoyDx® NGS kits, Zytomed Systems offers the AmoyDx® NGS Data Analysis System (ANDAS) from our partner company AmoyDx®.
After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
ZytoMax is now the exclusive distributor of AmoyDx® products in Switzerland
We are delighted to inform you that due to the positive customer response, the molecular diagnostic products of our partner AmoyDx® are now available to our customers in Switzerland through ZytoMax Schweiz GmbH, a sister company of Zytomed Systems GmbH.
PRAME (PReferentially-expressed Antigen in MElanoma) was first described in a paper by Ikeda et al., through analysis of the specificity of tumor-reactive T-cell clones derived from a patient with metastatic cutaneous melanoma. [1, 2]
As a manufacturer and distributor of in vitro diagnostics, our enterprise group with the companies Zytomed Systems GmbH and ZytoVision GmbH attaches great importance to the timely implementation of the requirements of the IVDR (Regulation (EU) 2017/746 of the European Parliament and of the Council of April 5th 2017 on in vitro diagnostic medical devices).